1. Home
  2. IMNM

IMNM

Immunome Inc.

Logo Immunome Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-18-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. It primarily operates in the U.S. Its current programs comprise Oncology (IMM-ONC-01), SARS-CoV-2 (IMM-BCP-01), and IMM20059 Anti-EPN1.

Founded: 2006 Country:
United States
United States
Employees: N/A City: BOTHELL
Market Cap: 1.5B IPO Year: 2020
Target Price: $34.00 AVG Volume (30 days): 748.9K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.38 EPS Growth: N/A
52 Week Low/High: $4.44 - $30.96 Next Earning Date: 05-03-2024
Revenue: $14,018,000 Revenue Growth: N/A
Revenue Growth (this year): -61.19% Revenue Growth (next year): N/A

Share on Social Networks: